All-trans-retinoic acid inhibits tumour growth of malignant pleural mesothelioma in mice

European Respiratory Journal

Volumn 34, Issue 5, 2009, Pages 1159-1166

  Tabata, C ^a   Tabata, R ^b   Hirayama, N ^a   Yasumitsu, A ^a   Yamada, S ^a   Murakami, A ^a   Iida, S ^a   Tamura, K ^a   Terada, T ^a   Kuribayashi, K ^a   Fukuoka, K ^a   Nakano, T ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b Hyogo Prefectural Tsukaguchi Hospital   (Japan)

Author keywords

Cytokines; Mesothelioma

Indexed keywords

ASBESTOS; CYTOKINE; INTERLEUKIN 6; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; RETINOIC ACID; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; LUNG FIBROBLAST; MESENCHYME CELL; MOUSE; NONHUMAN; PLEURA MESOTHELIOMA; PRIORITY JOURNAL;

ANIMALS; ASBESTOS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; INTERLEUKIN-6; MESOTHELIOMA; MICE; MICE, SCID; NEOPLASM TRANSPLANTATION; PLATELET-DERIVED GROWTH FACTOR; PLEURAL NEOPLASMS; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA1; TRETINOIN;

EID: 71049186094     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00195708     Document Type: Article

References (33)

1. Wagner JC, Sleggs CA, Marchand P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med 1960; 17: 260-271.
2. Selikoff IJ, Hammond EC, Seidman H. Latency of asbestos disease among insulation workers in the United States and Canada. Cancer 1980; 15: 2736-2740. (Pubitemid 11210245)
3. Nowak AK, Lake RA, Kindler HL, et al. New approaches for mesothelioma: biologics, vaccines, gene therapy, and other novel agents. Semin Oncol 2002; 29: 82-96.
4. Sterman DH, Kaiser LR, Albelda SM. Advances in the treatment of malignant pleural mesothelioma. Chest 1999; 116: 504-520. (Pubitemid 29382138)
5. Adachi Y, Aoki C, Yoshio-Hoshino N, et al. Interleukin-6 induces both cell growth and VEGF production in malignant mesotheliomas. Int J Cancer 2006; 119: 1303-1311. (Pubitemid 44258804)
6. Jagadeeswaran R, Ma PC, Seiwert TY, et al. Functional analysis of c-Met/hepatocyte growth factor pathway in malignant pleural mesothelioma. Cancer Res 2006; 66: 352-361. (Pubitemid 43166042)
7. Dubois C, Schlageter MH, de Gentile A, et al. Modulation of IL-8, IL-1β, and G-CSF secretion by all-trans retinoic acid in acute promyelocytic leukemia. Leukemia 1994; 8: 1750-1757.
8. Maeno T, Tanaka T, Sando Y, et al. Stimulation of vascular endothelial growth factor gene transcription by all trans retinoic acid through Sp1 and Sp3 sites in human bronchioloalveolar carcinoma cells. Am J Respir Cell Mol Biol 2002; 26: 246-253. (Pubitemid 34107880)
9. Pelicano L, Li F, Schindler C, et al. Retinoic acid enhances the expression of interferon-induced proteins: evidence for multiple mechanisms of action. Oncogene 1997; 15: 2349-2359. (Pubitemid 27496985)
10. Ogata A, Nishimoto N, Shima Y, et al. Inhibitory effect of all-trans retinoic acid on the growth of freshly isolated myeloma cells via interference with interleukin-6 signal transduction. Blood 1994; 84: 3040-3046. (Pubitemid 24328096)
11. Sidell N, Taga T, Hirano T, et al. Retinoic acid-induced growth inhibition of a human myeloma cell line via down-regulation of IL-6 receptors. J Immunol 1991; 146: 3809-3814.
12. Tabata C, Kubo H, Tabata R, et al. All-trans retinoic acid modulates radiation-induced proliferation of lung fibroblasts via IL-6/IL-6R system. Am J Physiol Lung Cell Mol Physiol 2006; 290: 597-606. (Pubitemid 43725105)
13. Tabata C, Kadokawa Y, Tabata R, et al. All-trans-retinoic acid prevents radiation- or bleomycin-induced pulmonary fibrosis. Am J Respir Crit Care Med 2006; 174: 1352-1360. (Pubitemid 44913037)
14. Jang BC, Jung TY, Paik JH, et al. Tetradecanoyl phorbol acetate induces expression of Toll-like receptor 2 in U937 cells: involvement of PKC, ERK, and NF-κB. Biochem Biophys Res Commun 2005; 328: 70-77.
15. Lee KY, Ito K, Hayashi R, et al. NF-kB and activator protein 1 response elements and the role of histone modifications in IL-1β-induced TGF-β1 gene transcription. J Immunol 2006; 176: 603-615. (Pubitemid 43023309)
16. Fritz DK, Kerr C, Tong L, et al. Oncostatin-M up-regulates VCAM-1 and synergizes with IL-4 in eotaxin expression: involvement of STAT6. J Immunol 2006; 176: 4352-4360. (Pubitemid 44264415)
17. Versnel MA, Claesson-Welsh L, Hammacher A, et al. Human malignant mesothelioma cell lines express PDGF β-receptors whereas cultured normal mesothelial cells express predominantly PDGF α-receptors. Oncogene 1991; 6: 2005-2011. (Pubitemid 21924040)
18. Ross R, Raines EW, Bowen-Pope DF. The biology of platelet-derived growth factor. Cell 1986; 46: 155-169.
19. Vogelzang NJ, Rusthoven JJ, Symanowski J, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 2003; 21: 2636-2644. (Pubitemid 46606305)
20. Gerwin BI, Lechner JF, Reddel RR, et al. Comparison of production of transforming growth factor-β and platelet-derived growth factor by normal human mesothelial cells and mesothelioma cell lines. Cancer Res 1987; 47: 6180-6184.
21. Noble PW, Henson PM, Lucas C, et al. Transforming growth factor-β primes macrophages to express inflammatory gene products in response to particulate stimuli by an autocrine/paracrine mechanism. J Immunol 1993; 151: 979-989. (Pubitemid 23215764)
22. Derynck R, Jarrett JA, Chen EY, et al. Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature 1985; 316: 701-705. (Pubitemid 16239342)
23. Sullivan DE, Ferris M, Pociask D, et al. Tumor necrosis factor-α induces transforming growth factor-β1 expression in lung fibroblasts through the extracellular signal-regulated kinase pathway. Am J Respir Cell Mol Biol 2005; 32: 342-349. (Pubitemid 40478310)
24. Yang H, Bocchetta M, Kroczynska B, et al. TNF-α inhibits asbestos-induced cytotoxicity via a NF-κB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis. Proc Natl Acad Sci USA 2006; 103: 10397-10402. (Pubitemid 44051178)
25. Suzuki E, Kim S, Cheung HK, et al. A novel small-molecule inhibitor of transforming growth factor β type I receptor kinase (SM16) inhibits murine mesothelioma tumor growth in vivo and prevents tumor recurrence after surgical resection. Cancer Res 2007; 67: 2351-2359. (Pubitemid 46424257)
26. Betsholtz C, Johnsson A, Heldin CH, et al. cDNA sequence and chromosomal localization of human platelet-derived growth factor A-chain and its expression in tumour cell lines. Nature 1986; 320: 695-699. (Pubitemid 16066787)
27. Eriksson A, Siegbahn A, Westermark B, et al. PDGF α- and β-receptors activate unique and common signal transduction pathways. EMBO J 1992; 11: 543-550.
28. Langerak AW, De Laat PA, Van Der Linden-Van Beurden CA, et al. Expression of platelet-derived growth factor (PDGF) and PDGF receptors in human malignant mesothelioma in vitro and in vivo. J Pathol 1996; 178: 151-160. (Pubitemid 26057966)
29. Heldin CH, Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 1999; 79: 1283-1316. (Pubitemid 29473317)
30. Scarpa S, Giuffrida A, Palumbo C, et al. Retinoic acid inhibits fibronectin and laminin synthesis and cell migration of human pleural mesothelioma in vitro. Oncol Rep 2002; 9: 205-209.
31. de Cupis A, Semino C, Pirani P, et al. Enhanced effectiveness of last generation antiblastic compounds vs. cisplatin on malignant pleural mesothelioma cell lines. Eur J Pharmacol 2003; 473: 83-95. (Pubitemid 36929872)
32. Quere R, Baudet A, Cassinat B, et al. Pharmacogenomic analysis of acute promyelocytic leukemia cells highlights CYP26 cytochrome metabolism in differential all-trans retinoic acid sensitivity. Blood 2007; 109: 4450-4460. (Pubitemid 46743415)
33. Chen SJ, Zhu YJ, Tong JH, et al. Rearrangements in the second intron of the RARA gene are present in a large majority of patients with acute promyelocytic leukemia and are used as molecular marker for retinoic acid-induced leukemic cell differentiation. Blood 1991; 78: 2696-2701.